title: Prostacyclin, thromboxane and antioxidant levels in pregnancy-induced hypertension.
abstract: 1. Plasma 6-keto-prostaglandin F1 alpha (6-keto-PGF 1 alpha, a major metabolite of prostacyclin), plasma thromboxane B2 (TXB2, a major metabolite of thromboxane A2) and five antioxidants (indirect markers of reactive oxygen species) namely, plasma thiol, erythrocyte lysate thiol, erythrocyte superoxide dismutase, plasma total glutathione and erythrocyte membrane thiol, were measured in 25 healthy non-pregnant women, 36 normotensive pregnant women and 35 women with pregnancy-induced hypertension (PIH). 2. The levels of TXB2 were significantly increased in normal pregnant women and PIH women with or without proteinuria compared with non-pregnant women. The concentrations of TXB2 in PIH women with proteinuria were higher than those without proteinuria (P < 0.05). 3. The levels of 6-keto-PGF1 alpha in healthy non-pregnant women and PIH women with or without proteinuria were significantly lower than that in normotensive pregnant women (all of three P < 0.01). There were no significant differences between healthy non-pregnant women and PIH women with and without proteinuria. 4. The ratio of TXB2 to 6-keto-PGF1 alpha was markedly elevated in PIH women with or without proteinuria compared with normotensive pregnant women and healthy non-pregnant women. The difference between PIH women with proteinuria and those without proteinuria was not significant (P > 0.05). 5. The levels of plasma thiol, superoxide dismutase and glutathione were significantly decreased in PIH women compared with normotensive pregnant women. 6. There were significant positive correlations between the levels of prostaglandins and antioxidant activity.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, University of Glasgow, Glasgow Royal Infirmary, UK.
authors.forename: G
authors.initials: G
authors.lastname: Chen
authors.forename: R
authors.initials: R
authors.lastname: Wilson
authors.forename: G
authors.initials: G
authors.lastname: Cumming
authors.forename: J J
authors.initials: JJ
authors.lastname: Walker
authors.forename: W E
authors.initials: WE
authors.lastname: Smith
authors.forename: J H
authors.initials: JH
authors.lastname: McKillop
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D015415:Biomarkers / Q000097:blood; D011464:Epoprostenol / Q000097:blood*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood*; D010084:Oxidation-Reduction; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000097:blood*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D013928:Thromboxane A2 / Q000097:blood*; D013929:Thromboxane B2 / Q000097:blood
chemical_list: D015415:Biomarkers; D017382:Reactive Oxygen Species; D013929:Thromboxane B2; D013928:Thromboxane A2; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol